NCT03714412View on ClinicalTrials.gov

Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System

NAWithdrawnINTERVENTIONAL

0

Timeline

Start Date

September 30, 2019

Primary Completion Date

December 15, 2019

Study Completion Date

December 15, 2023

Conditions

Mitral Regurgitation

Interventions

DEVICE

Implantation

Implantation of the Cardiovalve transfemoral mitral valve replacement system

Trial Locations (2)

Unknown

Hygeia Hospital, Athens

41-800

Silesian Center for Heart Diseases, Zabrze

Sponsors

Lead Sponsor

Cardiovalve Ltd.

All Listed Sponsors

lead

Cardiovalve Ltd.

INDUSTRY

NCT03714412 - Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System | Biotech Hunter | Biotech Hunter